Status:
COMPLETED
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo)
Lead Sponsor:
University Hospital, Caen
Collaborating Sponsors:
Centre Francois Baclesse
Conditions:
Apnea, Postanesthetic
Desaturation of Blood
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Suspension laryngoscopy is realised during apnea. In effect, surgeons are in the mouth of the patient and we can't have access at the aiways. So investigators like to use a Transnasal Humidified Rapi...
Eligibility Criteria
Inclusion
- suspension laryngoscopy
Exclusion
- THRIVE contraindication:
- epistaxis
- undrained pneumothorax
- Recent gastroesophageal surgery (1months)
- Skull Fractures
Key Trial Info
Start Date :
April 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 10 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03843580
Start Date
April 23 2019
End Date
February 10 2022
Last Update
February 18 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CaenUH
Caen, Normandy, France, 14000
2
Centre François Baclesse
Caen, France, 14000